Age Reversal Chemical Developed by Team of American & Australian Scientists

Published By : 26 Dec 2013 | Published By : QYRESEARCH

A team of scientists that had been conducting animal trials of a new age-reversing chemical compound has had a breakthrough with positive results emerging from the tests. The scientists-from Australia and America-are positive about the potency of this drug, and are now preparing for human trials of the chemical compound. 

The drug virtually works like a youth elixir as it shows the ability to reverse the process of muscle aging while simultaneously building up the tone of muscles and reducing inflammation. These tests, conducted on mice, also showed that it gave the creatures more energy.

During trials, scientists noted that much like the David Fincher-directed film The Curious Case of Benjamin Button, the drug rejuvenated muscle in mice by converting the 60-year-old muscle to around 20 years. However, the studies did not record an improvement in muscle strength. 

This study was centered on a chemical compound called NAD whose quantity in cells reduces with age. The study has been published in Cell-a medical journal. According to Prof David Sinclair who works at the Harvard Medical School in the U.S., he did not expect to see such aging being reversed in the trials; the anticipated results were mainly that aging could be slowed down.

The mice that were part of this study showed a 50% fall in NAD levels as they grew older. However, when they were administered the drug, scientists noted that the drug could raise the levels of NAD again. 

According to scientists working on the mice trials, mice that were two years old were administered the youth-medication for a week, after which the aging reversal was noted to appear. They recorded that the muscles of these two-year-old mice appeared similar to those of a mouse that’s six months old. Parameters on which comparisons were made included: insulin resistance, inflammation, muscle wastage and mitochondrial function.

As of now, clinical trials by the research team are slated to begin in 2015.
Back To Top